SCHEMBL7823554

SCHEMBL7823554

Cc1ccc(CCN2CCN[C@@H](Cc3c[nH]c4ccccc34)C2=O)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.57
▸ KMT2A Q03164 4/20 0.48
▸ SMN1; SMN2 Q16637 2/20 0.48
▸ MAPT P10636 2/20 0.48
▸ MEN1 O00255 2/20 0.48
▸ TP53 P04637 1/20 0.48
▸ GLA P06280 1/20 0.48
▸ CYP3A4 P08684 1/20 0.48
▸ THRB P10828 1/20 0.48
▸ IDO1 P14902 1/20 0.48
▸ RIPK1 Q13546 1/20 0.48
▸ HSD17B10 Q99714 1/20 0.48
▸ RAB9A P51151 1/20 0.47
▸ POLB P06746 3/20 0.47
▸ KDM4E B2RXH2 1/20 0.47
▸ ALDH1A1 P00352 1/20 0.47
▸ HPGD P15428 1/20 0.47
▸ HDAC1 Q13547 2/20 0.47
▸ HDAC8 Q9BY41 2/20 0.47
▸ HDAC6 Q9UBN7 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7823558 1.00 L3MBTL1 (0.57) L3MBTL1KMT2ASMN1; SMN2MAPTMEN1
SCHEMBL7836917 1.00 L3MBTL1 (0.57) L3MBTL1KMT2ASMN1; SMN2MAPTMEN1
SCHEMBL7825610 0.92 TACR1 (0.54) L3MBTL1KMT2ASMN1; SMN2MAPTMEN1
SCHEMBL7825447 0.92 TACR1 (0.54) L3MBTL1KMT2ASMN1; SMN2MAPTMEN1
SCHEMBL7825453 0.92 TACR1 (0.54) L3MBTL1KMT2ASMN1; SMN2MAPTMEN1
Hydrochloric Acid SCHEMBL7836549 0.91 TACR1 (0.53) L3MBTL1KMT2ASMN1; SMN2MAPTMEN1
Hydrochloric Acid SCHEMBL7836546 0.91 TACR1 (0.53) L3MBTL1KMT2ASMN1; SMN2MAPTMEN1
Hydrochloric Acid SCHEMBL7836860 0.91 TACR1 (0.53) L3MBTL1KMT2ASMN1; SMN2MAPTMEN1
SCHEMBL7836970 0.90 POLB (0.54) L3MBTL1KMT2ASMN1; SMN2MAPTMEN1
SCHEMBL7825214 0.90 POLB (0.54) L3MBTL1KMT2ASMN1; SMN2MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0815105-B1 HETEROCYCLIC SUBSTITUTED PIPERAZINONE DERIVATIVES AS TACHYKININ RECEPTOR ANTAGONISTS AVENTIS PHARMA INC (US) 2001-10-04 — — EP disclosed
EP-0815105-A1 HETEROCYCLIC SUBSTITUTED PIPERAZINONE DERIVATIVES AS TACHYKININ RECEPTOR ANTAGONISTS HOECHST MARION ROUSSEL, INC. (US) 1998-01-07 — — EP disclosed
WO-1996028441-A1 HETEROCYCLIC SUBSTITUTED PIPERAZINONE DERIVATIVES AS TACHYKININ RECEPTOR ANTAGONISTS HOECHST MARION ROUSSEL, INC. (US) 1996-09-19 — — WO disclosed
Send feedback